These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9545164)
1. Subcutaneous enoxaparin for outpatient anticoagulation therapy in a patient with an aortic valve replacement. Manley HJ; Smith JA; Garris RE Pharmacotherapy; 1998; 18(2):408-12. PubMed ID: 9545164 [TBL] [Abstract][Full Text] [Related]
2. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063 [TBL] [Abstract][Full Text] [Related]
3. A practical approach for bridging anticoagulation after mechanical heart valve replacement. Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932 [TBL] [Abstract][Full Text] [Related]
4. In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation. Thompson JL; Sundt TM; Sarano ME; Santrach PJ; Schaff HV Ann Thorac Surg; 2008 Jun; 85(6):2046-50. PubMed ID: 18498817 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves. McKellar SH; Abel S; Camp CL; Suri RM; Ereth MH; Schaff HV J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1410-6. PubMed ID: 21429525 [TBL] [Abstract][Full Text] [Related]
6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
7. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347 [TBL] [Abstract][Full Text] [Related]
16. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia. Willenborg KL Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA; Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716 [TBL] [Abstract][Full Text] [Related]
18. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442 [TBL] [Abstract][Full Text] [Related]
19. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey. Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058 [TBL] [Abstract][Full Text] [Related]